Inhibition of malignant angiogenesis
- 1 July 1997
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 23 (4) , 263-286
- https://doi.org/10.1016/s0305-7372(97)90014-1
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells?European Journal Of Cancer, 1994
- Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferationJournal of Cellular Biochemistry, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Suramin in advanced platinum-resistant ovarian cancerEuropean Journal Of Cancer, 1992
- Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitorBiochemical and Biophysical Research Communications, 1991
- Specific inhibition of endothelial cell proliferation by thrombospondinBiochemical and Biophysical Research Communications, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Inhibition of angiogenesis by bleomycin and its copper complex.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971